CLINICAL_TRIALS ClinicalTrials.gov record update

Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03172455
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:00.644874+00:00
Published At: 2020-10-05T00:00:00+00:00
Record Updated At: 2020-10-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Acute-graft-versus-host Disease", "Steroid Refractory Acute Graft Versus Host Disease", "Graft-versus-host-disease", "Graft Vs Host Disease", "Alpha 1-Antitrypsin Deficiency", "Alpha-1 Proteinase Inhibitor", "Alpha-1 Protease Inhibitor Deficiency", "Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-10-05"
protocolSection.identificationModule.nctId: "NCT03172455"
protocolSection.identificationModule.officialTitle: "Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)"
protocolSection.statusModule.overallStatus: "NO_LONGER_AVAILABLE"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.